As a key part of our work in predictive biology, The Cube Initiative launched with a bold two-year proof-of-concept project that focuses first on a single disease entity: type 2 diabetes.
To unlock the genetic and biological complexity of type 2 diabetes, through the power of mouse models, human data and computational power so that we can make clinical predictions and uncover unique biomedical solutions that can be translated into the clinic.
JAX researchers are focused on integrating and analyzing the thousands of rich datasets that have resulted from this two-year, large scale type 2 diabetes data generation.
Target acquired. Using specialized mouse models and the latest technology, JAX scientists are working to curb one of the most common chronic diseases affecting people worldwide.
A new study published in Nature sets a new precedent for understanding the development of type 2 diabetes, and it provides a trove of data for ongoing research.
JAX diabetes researcher explores the genetic variations that influence susceptibility to insulin resistance and type 2 diabetes.